Accenture, a technology services company, has gotten executives from CVS and Rite Aid to join a group of industry leaders who will assess the potential of radio frequency identification (RFID) technology. Accenture is serving as program manager for the group of pharmaceutical manufacturers, distributors, and retailers. Also, the Healthcare Distribution Management Association and the National Association of Chain Drug Stores are lending their support by providing their members with additional information and education-related opportunities for the program, according to Accenture.
The project will look at application of RFID in 3 areas:
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs